Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3020% below fair value
$2.90−0.10 (-3.33%)
Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –
Nephros operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nephros's operating cash flow for the twelve months ending Jun 30, 2026 was -$706.00K, down 135.4% year over year. For fiscal 2025 it was $1.60M. The highest annual figure on record is $1.60M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.60M | – |
| FY2024 | Dec 31, 2024 | -$492.00K | -159.5% |
| FY2023 | Dec 31, 2023 | $827.00K | – |
| FY2022 | Dec 31, 2022 | -$3.23M | – |
| FY2021 | Dec 31, 2021 | -$1.42M | – |
| FY2020 | Dec 31, 2020 | -$6.90M | – |
| FY2019 | Dec 31, 2019 | -$2.28M | – |
| FY2018 | Dec 31, 2018 | -$3.66M | – |
| FY2017 | Dec 31, 2017 | -$77.00K | – |
| FY2016 | Dec 31, 2016 | -$2.11M | – |
| FY2015 | Dec 31, 2015 | -$3.82M | – |
| FY2014 | Dec 31, 2014 | -$2.50M | – |
| FY2013 | Dec 31, 2013 | -$3.58M | – |
| FY2012 | Dec 31, 2012 | -$1.55M | – |
| FY2011 | Dec 31, 2011 | -$1.30M | – |
| FY2010 | Dec 31, 2010 | -$1.29M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $681.00K | -31.5% |
| Q1 FY2026 | Mar 31, 2026 | -$1.67M | -618.9% |
| Q4 FY2025 | Dec 31, 2025 | $185.00K | -85.8% |
| Q3 FY2025 | Sep 30, 2025 | $99.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $994.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $322.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $1.30M | – |
| Q3 FY2024 | Sep 30, 2024 | -$623.00K | -210.9% |
| Q2 FY2024 | Jun 30, 2024 | -$501.00K | -321.7% |
| Q1 FY2024 | Mar 31, 2024 | -$672.00K | -343.5% |
| Q4 FY2023 | Dec 31, 2023 | -$237.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $562.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $226.00K | – |
| Q1 FY2023 | Mar 31, 2023 | $276.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$195.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$170.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.07M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.80M | – |
| Q4 FY2021 | Dec 31, 2021 | -$335.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$910.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$117.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$55.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.53M | -519.2% |
| Q3 FY2020 | Sep 30, 2020 | -$1.82M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.72M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.84M | – |
| Q4 FY2019 | Dec 31, 2019 | $364.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$614.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.33M | – |
| Q1 FY2019 | Mar 31, 2019 | -$697.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$528.00K | -129.4% |
| Q3 FY2018 | Sep 30, 2018 | -$1.12M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.34M | – |
| Q1 FY2018 | Mar 31, 2018 | -$669.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $1.79M | – |
| Q3 FY2017 | Sep 30, 2017 | -$713.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$499.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$659.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$528.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$790.00K | – |
See a number that looks wrong?